ArticleFrontiers in allergy2024

The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years.

V Schichter-Konfino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.